Moderna posts $18bn profit for 2021 amid calls for patent waiver
Moderna has posted $18.5 billion revenue from COVID-19 vaccine sales in the 2021 full year amid growing calls for manufacturers...
Moderna has posted $18.5 billion revenue from COVID-19 vaccine sales in the 2021 full year amid growing calls for manufacturers...
Evidence on the need for a widespread administration booster doses, following primary vaccination rounds remains limited and inconclusive, the World...
Pfizer’s booster shot could be ready by September 20th 2021, in line with the previous deadline set by the White...
The bulging bubble from Covid-19 vaccines production has lifted Moderna to the largest profitable quarter ever recorded in its 10...
The US Bio-tech firm Moderna’s experimental coronavirus vaccine appears to be safe and elicits an immune response in all age...